Tissue Regenix Group says "disciplined approach" paying off at half-year stage - Danny Lee, CEO, Tissue Regenix Group 00:00:00

Share On Facebook Share On Twitter

Tissue Regenix Group PLC (AIM:TRX) chief executive Danny Lee and chief financial officer David Cocke speak to Thomas Warner from Proactive London after the regenerative medicine company released its interim results for the first six months of 2023.

Recent Videos